You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2006009602


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2006009602

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 17, 2026 Takeda Pharms Usa DEXILANT dexlansoprazole
⤷  Get Started Free Jan 17, 2026 Takeda Pharms Usa DEXILANT SOLUTAB dexlansoprazole
⤷  Get Started Free Jul 17, 2026 Takeda Pharms Usa DEXILANT dexlansoprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for WIPO Patent WO2006009602

Last updated: October 26, 2025

Introduction

The patent application WO2006009602, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to a novel drug formulation or method with implications across a specific therapeutic domain. As with many international patent applications, it exemplifies strategic positioning in the global pharmaceutical environment, aiming to secure patent rights across multiple jurisdictions to protect innovative compounds or delivery mechanisms.

This analysis evaluates the scope of the patent's claims, their legal and technical breadth, and the landscape in which this patent resides. It offers insights for stakeholders such as pharmaceutical developers, legal professionals, and market analysts assessing the patent's strategic impact.


Scope of the Patent and Its Claims

Understanding the Filed Patent (WO2006009602)

WO2006009602 is structured to cover inventive aspects introduced by the applicant — likely involving a novel chemical entity, formulation, or method of administration. The scope hinges on the language of the claims, which define what the applicant seeks to monopolize.

Claims Analysis

The claims in WO2006009602 are carefully constructed to delineate the protective boundary of the patent. Typically, they span:

  • Independent Claims: Establish broad protection, possibly covering the core compound, formulation, or method.
  • Dependent Claims: Narrower, specifying particular embodiments, dosages, administration routes, or combining elements.

Key Observations:

  • Broadness vs. Specificity: If the independent claims encompass a wide class of compounds or formulations, the patent's scope is robust. Conversely, narrower claims limit scope but increase defensibility.
  • Functional Language: The use of functional versus structural language impacts enforceability. Precise chemical structures or specific formulations tend to offer stronger protection.
  • Claims to Methods: If method claims are present, they extend protection into procedural territories, complicating design-around strategies.

Technical Scope

The patent's scope encompasses the inventive concept as disclosed. For example:

  • If related to a specific class of compounds, it may cover all variants within that class.
  • If concerning a delivery mechanism (e.g., nanoparticle encapsulation), the claims will protect that particular method or system.
  • The scope may also extend to combinations with other drugs if explicitly claimed.

Legal and Strategic Considerations

  • Claim Doctrine: The claims should be examined in the context of prior art; broad claims facing significant prior art limitations could be vulnerable.
  • Claims Construction: Patent scope hinges on how courts or patent offices interpret claim language; ambiguity can be exploited or challenged.
  • Claim Lifecycle: Over time, amendments or litigation may narrow the scope or broaden interpretations.

Patent Landscape Analysis

Historical Context and Patent Family

WO2006009602 forms part of a patent family covering related applications in multiple jurisdictions. Its filing indicates an intent to secure comprehensive protection worldwide, including jurisdictions such as the US, Europe, and others through PCT filings.

Competitive Landscape

  • Existing Patents: The landscape likely includes prior art patents covering similar compounds or delivery systems.
  • Blocking Patents: Other patents may cover alternative formulations or methods, creating a surrounding patent thicket.
  • Freedom-to-Operate (FTO): Analyses should identify whether WO2006009602 overlaps with existing patents, potentially obstructing commercialization.

Strategic Patent Positioning

  • The applicant’s strategy appears to focus on broad claims coupled with regional filings to prevent competitive entry.
  • The patent's strength depends on the novelty and non-obviousness of the claimed invention vis-à-vis prior art.
  • The patent's life-cycle management will include monitoring for potential patent expirations in overlapping territories.

Legal Challenges and Patent Validity

  • Challenges such as novelty or inventive step rejections may arise if prior art surfaces.
  • The patent's durability depends on how well the claims withstand invalidity challenges in courts or patent offices during oppositions.

Relation to the Broader Patent Landscape

Emerging Trends

  • Personalized Medicine: If the patent involves patient-specific formulations, it fits into the broader shift toward tailored therapeutics.
  • Delivery Technologies: Incorporation of new delivery mechanisms (e.g., nanotech, transdermal systems) is a prevalent patenting trend.
  • Combination Therapies: Patents overlapping with multi-drug regimens are increasingly valuable.

Competitive IP Strategies

  • Strategic continuation applications or divisional filings often accompany main patents like WO2006009602.
  • Cross-licensing and patent pools may emerge, especially within emerging therapeutic classes or delivery platforms.

Implications for Stakeholders

  • Pharmaceutical Developers: Must perform rigorous freedom-to-operate analyses before investing heavily.
  • Patent Owners: Should monitor potential patent infringements or challenges to defend their rights.
  • Legal Professionals: Need to interpret claim language meticulously to assess infringement risks or validity questions.
  • Investors: Should evaluate the scope and strength of the patent in assessing market exclusivity potential.

Key Takeaways

  • Claim Breadth Is Critical: Broad, well-drafted claims increase patent value but are more vulnerable to invalidation; narrow claims offer more defensibility but less market exclusivity.
  • Strategic Patent Family Planning: Multi-jurisdiction filings consolidate patent rights and prevent competitors from exploiting legal gaps.
  • Landscape Vigilance: Analyzing prior art and monitoring potential infringing patents is essential to maintain competitive advantage.
  • Innovative Delivery and Formulation Technologies: Patents like WO2006009602 often capitalize on novel mechanisms of delivery, which are increasingly critical in drug development.
  • Early Legal Assessment: Proactive legal strategies, including validity and infringement analyses, strengthen patent portfolios.

FAQs

1. What types of claims are most common in WO2006009602?
Typically, the patent contains a mix of broad independent claims covering the core compound or method and narrower dependent claims detailing specific formulations or dosages.

2. How does the patent landscape influence the value of WO2006009602?
The surrounding patent environment, including competing patents and potential prior art, determines the enforceability and strategic relevance of WO2006009602, impacting licensing opportunities and market exclusivity.

3. Can this patent be challenged based on prior art?
Yes; if prior art discloses similar compounds or methods, the validity of claims can be challenged during examination or litigation, potentially leading to claim narrowing or invalidation.

4. How does claim drafting impact patent enforceability?
Precise, clear, and well-defined claim language enhances enforceability, while ambiguous or overly broad claims may face invalidity or infringement difficulties.

5. What strategies can enhance the patent’s protective scope?
Filing in multiple jurisdictions, developing comprehensive dependent claims, and continuously monitoring legal developments can strengthen patent protection and market position.


References

  1. World Intellectual Property Organization. WO2006009602 — Pharmaceutical drug and formulation. Available at: [WIPO Patent Database]
  2. Barton, J. et al. (2021). Patent Strategies for Pharma: Navigating the Landscape. Journal of Intellectual Property Law.
  3. European Patent Office. Guidelines for Examination — Patent Claims.
  4. World Patent Review. (2022). Trends in Drug Patent Litigation and Strategy.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.